ADVM | Adverum Biotechnologies Inc
Category: Consumer goods
Quick infos Headquarters: Menlo Park, California, United States Trade prices Volume: Market Cap: 116.55M Prev closed: 9.86 Open: 9.91 High: 10.33 Low: 9.82 52 week low: 8.58 52 week high: 26.98 Dividends: No Dividends Next ER: May 10, 2023
About the Company Adverum Biotechnologies, formerly known as Avalanche Biotechnologies, is a publicly traded clinical stage gene therapy company located in Redwood City, California.
Earnings History Date EPS / Forecast Revenue / Forecast May 10, 2023 March 30, 2023 -0.33 / -0.36- / -March 13, 2023 - / -0.36- / -November 10, 2022 -0.4 / -0.35- / -August 11, 2022 -0.44 / -0.34- / -view more
Historical Data Date Price Open High Low Vol Change ER Aug 4, 2022 1.510 1.390 1.560
1.340
460.50K 8.63% Aug 3, 2022 1.390 1.320 1.415
1.270
902.10K 6.11% Aug 2, 2022 1.310 1.360 1.400
1.300
280.09K -5.07% Aug 1, 2022 1.380 1.460 1.500
1.360
571.80K -5.48% Jul 29, 2022 1.460 1.510 1.520
1.460
265.10K -5.81% Jul 28, 2022 1.550 1.610 1.610
1.530
219.51K -3.73% Jul 27, 2022 1.610 1.570 1.645
1.540
211.14K 3.87% Jul 26, 2022 1.550 1.510 1.600
1.510
200.46K 0% Jul 25, 2022 1.550 1.580 1.600
1.520
596.14K -1.9% Jul 22, 2022 1.580 1.720 1.720
1.570
298.18K -8.14% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:2006 Employees:167 News
Adverum Biotechnologies GAAP EPS of -$0.40 misses by $0.06 seekingalpha.com Nov 11, 2022 6:36 am Adverum Biotech doses first subject in phase 2 trial to treat wet AMD seekingalpha.com Sep 14, 2022 11:39 pm Adverum Biotechnologies GAAP EPS of -$0.44 misses by $0.10 seekingalpha.com Aug 12, 2022 5:26 am
Adverum Files Investor Presentation Highlighting Significant Strategic Progress and Purpose-Built Board to Oversee Stockholder Value Creation finance.yahoo.com Jul 8, 2022 4:15 pm
Adverum Announces Shortened Timelines and Clear Development Path for ADVM-022 Intravitreal Gene Therapy in Wet AMD, Reports Recent Business Progress and Fourth Quarter 2020 Financial Results finance.yahoo.com Jul 8, 2022 4:00 pm
30 Stocks Moving In Monday's Mid-Day Session finance.yahoo.com Jul 8, 2022 12:06 pm
Adverum (ADVM) Completes IND Amendment for Gene Therapy Study finance.yahoo.com Jul 8, 2022 11:22 am
Glass Lewis Joins ISS In Recommending Adverum Shareholders Vote for All Three Independent Sonic Director Nominees finance.yahoo.com Jul 8, 2022 9:48 am
Adverum Biotechnologies Provides ADVM-022 Development Update and Anticipated Corporate Milestones for 2022 finance.yahoo.com Jul 8, 2022 8:00 am
Adverum Biotechnologies Announces Upcoming Data Presentation at ASRS 2022 finance.yahoo.com Jul 8, 2022 8:00 am
Adverum Moves Forward With IND Amendment For ADVM-022 Phase 2 Trial In Wet AMD finance.yahoo.com Jul 8, 2022 7:30 am
Adverum Bio Posts Additional Efficacy, Safety Data From ADVM-022 Gene Therapy In Wet AMD finance.yahoo.com Jul 8, 2022 6:59 am
Adverum's Stock Crashes After DME Gene Therapy Trial Derails On One Patient's Serious Adverse Event finance.yahoo.com Jul 8, 2022 5:32 am Adverum gains 13% to reach three-month high after Truist upgrade seekingalpha.com Jul 7, 2022 10:29 pm
Adverum Biotechnologies Completes IND Amendment and Prepares to Initiate the Phase 2 LUNA Trial of ADVM-022 in Wet AMD finance.yahoo.com Jul 6, 2022 4:05 pm
Adverum Biotechnologies Granted Priority Medicines (PRIME) Designation by European Medicines Agency for ADVM-022 in Wet AMD finance.yahoo.com Jun 24, 2022 8:00 am Adverum wet AMD candidate ADVM-022 shows long-term benefit after single injection seekingalpha.com Jun 9, 2022 10:47 pm
Adverum Biotechnologies Announces New Data at the Macula Societys 2022 Annual Meeting finance.yahoo.com Jun 2, 2022 4:05 pm
Adverum's Data at ASGCT Further Supports Phase 2 Development Plans For Wet-AMD Gene Therapy finance.yahoo.com May 18, 2022 8:11 am Adverum Biotechnologies GAAP EPS of -$0.38 misses by $0.07 seekingalpha.com May 13, 2022 4:52 am This company doesn't provide a dividend.
Key Persons Chairman : Chairperson: Paul B Cleveland Talk about Adverum Biotechnologies Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 86 HOLD 14 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Very few careers can offer you the freedom, flexibility, and income that day trading does. As a day trader, you can live and work anywhere in the world. You can decide when to work and when not to work. You only answer to yourself. That is the life of the successful day trader. Many people aspire to it, but very few succeed.
A Beginner's Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology